RecruitingNot ApplicableNCT06915974
Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients
Sponsor
Ain Shams University
Enrollment
70 participants
Start Date
Jan 10, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.
Eligibility
Min Age: 25 YearsMax Age: 60 Years
Inclusion Criteria4
- Patients with acute burn admitted to burn ICU within 24 hours from the burn incidence.
- patients with burn percentage of 25% to 50% of total body surface area
- patients with second to third degree burns
- ASA 1 and ASA 2 patients
Exclusion Criteria4
- Burn percentage more than 50% or less than 25% of total body surface area
- Having autoimmune diseases
- Cancer patients
- ASA 3 and ASA 4 patients
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTInterleukin 6
Interleukin 6 and procalcitonin will be sampled for all patients on days 1, 3, 7, and 10
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06915974
Related Trials
Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?
NCT035474141 location
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT0717927628 locations
TIMP2*IGFBP7 and Transient AKI
NCT034720791 location
ICU Combined Assessment of Cardio-Respiratory Exercise
NCT061939802 locations
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
NCT0685464020 locations